Patents by Inventor Adrian Simmonds

Adrian Simmonds has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7078499
    Abstract: Nucleotides comprising a reporter moiety and a polymerase enzyme blocking moiety in which the reporter moiety does not also act as a polymerase enzyme blocking moiety are described. Also described are compounds of Formula (I): wherein W is a phosphate group, B is a base, Y is a linker comprising an enzyme-cleavable group, R2 is a reporter moiety, R3 is selected from H or OH, Z and Z? are selected from H, OH, or a group X—R1, wherein X is a linker comprising an enzyme-cleavable group and R1 is a polymerase enzyme blocking group, provided that at least one of Z and Z? is X—R1.
    Type: Grant
    Filed: May 31, 2001
    Date of Patent: July 18, 2006
    Assignee: GE Healthcare UK Limited
    Inventors: Raj Odedra, Adrian Simmonds, Lee Pickering
  • Publication number: 20050233462
    Abstract: A matched set of fluorescent dyes is provided, wherein each dye of the set is capable of covalent attachment to a protein and wherein each of the dyes has a molecular structure and a charge that is matched one with the other, such that relative electrophoretic mobility of a protein labelled with one dye of the set is the same as the electrophoretic mobility of the protein labelled with a different dye of the set. The matched set comprises at least two different fluorescent dyes of formula: wherein n is 1, 2, or 3; Z1 and Z2 independently represent the carbon atoms necessary to complete a phenyl or naphthyl ring system; one of groups R1 and R2 is a target bonding group; remaining group R1 or R2 is selected from —(CH2)4—W or —(CH2)r—H; group R3 is hydrogen, except when either R1 or R2 is —(CH2)r—H, in which case R3 is W; and W is selected from sulphonic acid and sulphonate.
    Type: Application
    Filed: July 8, 2002
    Publication date: October 20, 2005
    Inventors: Karen Williams, Timothy Stone, Adrian Simmonds, Alison Sweet, Susan Fowler
  • Publication number: 20050164182
    Abstract: The invention relates to nucleosides comprising a reporter moiety which also functions to limit polymerase activity, characterised in that the reporter moiety is attached to the nucleoside through a linkage group cleavable by a hydrolase enzyme wherein the hydrolase enzyme is selected from the group consisting of esterases, phosphatases, peptidases, penicillin amidases, glycosidases and phosphorylases.
    Type: Application
    Filed: November 28, 2002
    Publication date: July 28, 2005
    Inventors: Lea Pickering, Raj Odedra, Adrian Simmonds, Karin Johnson
  • Publication number: 20030194722
    Abstract: Nucleotides comprising a reporter moiety and a polymerase enzyme blocking moiety in which the reporter moiety does not also act as a polymerase enzyme blocking moiety are described. Also described are compounds of Formula (I): wherein W is a phosphate group, B is a base, Y is a linker comprising an enzyme-cleavable group, R2 is a reporter moiety, R3 is selected from H or OH, Z and Z′ are selected from H, OH, or a group X—R1, wherein X is a linker comprising an enzyme-cleavable group and R1 is a polymerase enzyme blocking group, provided that at least one of Z and Z′ is X—R1.
    Type: Application
    Filed: March 24, 2003
    Publication date: October 16, 2003
    Inventors: Raj Odedra, Adrian Simmonds, Lee Pickering
  • Patent number: 6313286
    Abstract: Nucleoside analogues containing the degenerate base analogue P and derivatives thereof are provided with reporter moieties preferably comprising signal moieties. The nucleoside analogues are useful for labeling DNA or RNA or for incorporating in oligonucleotides.
    Type: Grant
    Filed: February 5, 1999
    Date of Patent: November 6, 2001
    Assignee: Amersham Pharmacia Biotech UK Limited
    Inventors: Daniel Brown, Alan Hamilton, David Loakes, Adrian Simmonds, Clifford Smith
  • Patent number: 6239159
    Abstract: Nucleoside analogues in which a group M replaces the natural base where M is (1) or (2) or (3), where each of X1, X2 and X3 are C or N, each of R6 and R7 is the same or different and each is H, NO2, CO, COR8, OR8, CN, O, CON(R8)2, COOR8, SO2R8, SO3R8, SR8, NHCHO, (CH2)n(R8)2, halogen, or a reporter moiety, each of R8 and R9 is H or hydrocarbyl or a reporter moiety, and n is 0-4. The analogues are substrates for polymerase and terminal transferase enzymes.
    Type: Grant
    Filed: May 3, 1999
    Date of Patent: May 29, 2001
    Assignee: Amersham Pharmacia Biotech UK Limited
    Inventors: Daniel Brown, David Loakes, Alan Hamilton, Adrian Simmonds, Clifford Smith
  • Patent number: 6166202
    Abstract: Benzophenoxazine compounds have formula (I) where X is O or NH, Y is NR.sup.1 R.sup.2 or H, R.sup.1 and R.sup.2 are alkyl or -L-A, L is a linker and A may be a reactive group by means of which the compound is linked to a biomolecule. The compounds can be used as fluorescent dyes for labelling biomolecules.
    Type: Grant
    Filed: January 15, 1999
    Date of Patent: December 26, 2000
    Assignee: Amersham Pharmacia Biotech UK Limited
    Inventors: Adrian Simmonds, James N Miller, Christopher John Moody, Elizabeth Swann, Mark Samuel Jonathan Briggs, Ian Edward Bruce